All In Biotech

Free tool

Drugs in development

Investigational drugs and biologics in industry-sponsored Phase 2 and Phase 3 trials that are active or finished in the last two years, and that FDA has not approved. Built from 10,322 ClinicalTrials.gov records, with code names and generic names merged. For approved drugs, use Drug Search.

Last checked: Nov 20, 2026Latest source record: rebuilt Nov 18, 2026Source: ClinicalTrials.govMethods & limitations

Drugs in development

3,685

Not FDA-approved

In Phase 3

1,424

Highest phase reached

Matching your filters

3,685

Reset

3,685 drugs in development

Names, sponsors and conditions come from the trial records. Click a drug for its trials.

  • SIPI6398Phase 21 trial

    Shanghai Zhongze Therapeutics Co., Ltd. · Schizophrenia Disorder

  • SIR2501Phase 21 trial

    Sironax USA, Inc. · Chemotherapy-induced Peripheral Neuropathy

  • SKB105Phase 21 trial

    Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. · Advanced Solid Tumors

  • SKB315Phase 21 trial

    Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. · Gastroesophageal Junction Adenocarcinoma

  • SKB565Phase 21 trial

    Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. · Advanced Solid Tumors

  • SKLB1028Phase 21 trial

    CSPC ZhongQi Pharmaceutical Technology Co., Ltd. · Newly Diagnosed Acute Myeloid Leukemia (AML)

  • SKX-16Luliconazole 10%Phase 21 trial

    SATO Pharmaceutical Co., Ltd. · Onychomycosis of Toenails

  • SL-28Phase 21 trial

    Second Life Therapeutics · Head & Neck Cancer, Pancreas Carcinoma, Pancreas Cancer, Metastatic

  • SLN124Phase 21 trial

    Silence Therapeutics plc · Polycythemia Vera

  • SMP-656Phase 21 trial

    Chengdu SciMount Pharmatech Co., Ltd. · HER2-positive Breast Cancer, Metastatic Breast Cancer, Locally Advanced Breast Cancer (LABC)

  • SMP3124LPPhase 21 trial

    Sumitomo Pharma America, Inc. · Solid Tumor

  • SNB-101Phase 21 trial

    SN BioScience · Patient is Not Suitable for Complete Surgical Resection With a Cytologically or Histologically Confirmed Small Cell Lung Cancer(SCLC)

  • SNH-119014Phase 21 trial

    ScinnoHub Pharmaceutical Co., Ltd. · Thalassemia

  • SNP-610Phase 21 trial

    Sinew Pharma Inc. · NASH - Nonalcoholic Steatohepatitis

  • SNP318Phase 21 trial

    SciNeuro · Diabetic Macular Edema, DME

  • SNS-101anti-VISTAPhase 21 trial

    Sensei Biotherapeutics, Inc. · Solid Tumor, Adult, Advanced Solid Tumor, Head and Neck Cancer

  • SNUG01Phase 21 trial

    SineuGene Therapeutics Co., Ltd. · Amyotrophic Lateral Sclerosis (ALS)

  • SNV4818Phase 21 trial

    Pikavation Therapeutics, Inc. · Advanced Solid Tumors

  • SOA101Phase 21 trial

    Shine-On Biomedical Co., Ltd. · Solid Tumors

  • SolbinsiranLY3561774Phase 21 trial

    Eli Lilly · Severe Hypertriglyceridemia

  • SOM-401Phase 21 trial

    Inflammasome Therapeutics · Geographic Atrophy, Age-Related Macular Degeneration

  • SOM001-APhase 21 trial

    Somnum Pharma Inc. · Chronic Insomnia

  • SOM001-BPhase 21 trial

    Somnum Pharma Inc. · Chronic Insomnia

  • SOM001-CPhase 21 trial

    Somnum Pharma Inc. · Chronic Insomnia

  • SOM001-DPhase 21 trial

    Somnum Pharma Inc. · Chronic Insomnia

  • SOT106Phase 21 trial

    SOTIO Biotech a.s. · Osteosarcoma Metastatic, Soft Tissue Sarcoma (STS), Osteosarcoma, Advanced

  • SOT109Phase 21 trial

    SOTIO Biotech a.s. · Colorectal Cancer (Locally Advanced or Metastatic)

  • SotevtamabAB-16B5Phase 21 trial

    Alethia Biotherapeutics · Metastatic Colorectal Cancer

  • SP-002Phase 21 trial

    Stamford Pharmaceuticals, Inc. · Basal Cell Carcinoma

  • SP-420Phase 21 trial

    Pharmacosmos A/S · Beta Thalassemia Major Anemia, Myelodysplastic Syndrome

  • SP-624Phase 21 trial

    Sirtsei Pharmaceuticals, Inc. · Major Depressive Disorder

  • spartalizumabPDR001Phase 21 trial

    Novartis · Myelodysplastic Syndromes, Leukemia, Myelomonocytic, Chronic

  • SPC 2002Phase 21 trial

    Shin Poong Pharmaceutical Co. Ltd. · Hypertension, Essential, Cardiovascular Diseases, Cardiology

  • SPC 2003Phase 21 trial

    Shin Poong Pharmaceutical Co. Ltd. · Hypertension, Essential, Cardiovascular Diseases, Cardiology

  • SPC 2004Phase 21 trial

    Shin Poong Pharmaceutical Co. Ltd. · Hypertension, Essential, Cardiovascular Diseases, Cardiology

  • SPC1001Phase 21 trial

    Shin Poong Pharmaceutical Co. Ltd. · Hypertension (HTN), NYHA Class III Heart Failure, NYHA Class IV Heart Failure

  • SPC5002Phase 21 trial

    Shin Poong Pharmaceutical Co. Ltd. · Hypertension (HTN), NYHA Class III Heart Failure, NYHA Class IV Heart Failure

  • SPC5003Phase 21 trial

    Shin Poong Pharmaceutical Co. Ltd. · Hypertension (HTN), NYHA Class III Heart Failure, NYHA Class IV Heart Failure

  • SPC5004Phase 21 trial

    Shin Poong Pharmaceutical Co. Ltd. · Hypertension (HTN), NYHA Class III Heart Failure, NYHA Class IV Heart Failure

  • SPH3127Phase 21 trial

    Shanghai Pharmaceuticals Holding Co., Ltd · Diabetic Kidney Disease

  • SPH5030Phase 21 trial

    Shanghai Pharmaceuticals Holding Co., Ltd · Biliary Tract or Colorectal Cancer With Her2-positive/Mutated

  • SPK-8011QQRO7878488Phase 21 trial

    Roche (Genentech) · Hemophilia A

  • SPL84Phase 21 trial

    SpliSense Ltd. · Cystic Fibrosis

  • SPN-821Phase 21 trial

    Supernus Pharmaceuticals, Inc. · Major Depressive Disorder (MDD)

  • SPVN06Phase 21 trial

    SparingVision · Retinitis Pigmentosa

  • SPVN20Phase 21 trial

    SparingVision · Retinitis Pigmentosa (RP), Rod Cone Dystrophy

  • SR1375Phase 21 trial

    Shanghai SIMR Biotechnology Co., Ltd. · Community-acquired Pneumonia

  • SR750Phase 21 trial

    Shanghai SIMR Biotechnology Co., Ltd. · Trigeminal Neuralgia

  • SRD-001Phase 21 trial

    Sardocor Corp. · Congestive Heart Failure, Heart Failure, Systolic, Heart Failure

  • SRP-001Phase 21 trial

    South Rampart Pharma, Inc. · Acute Pain, Postoperative Pain, Pain

NewerPage 69 of 74Older

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.